This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (19)  • Contact me when this article is cited  Related Content  • Related letters  • Similar articles in JAMA  Topic Collections  • Medical Practice  • Conflict of Interest  • Medical Education  • Medical Ethics  • Drug Therapy  • Drug Therapy, Other  • Alert me on articles by topic  Social Bookmarking   What's this?

ACCME's Proposed New Guidelines for Commercial Support of CME

Arnold S. Relman, MD

JAMA. 2003;289:2418-2420.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

On January 14 of this year, the Accreditation Council on Continuing Medical Education (ACCME) released a draft of proposed new and stronger standards for the commercial support of continuing medical education (CME)¹ and requested comments from the medical community. The following month, the Washington Legal Foundation (WLF), a legal think tank, issued a highly critical commentary,² in which it recommended that the ACCME withdraw its proposals because they were unnecessary, counterproductive, and possibly even illegal. Both the proposed new ACCME standards and the WLF critique raise issues of the greatest importance to our profession with respect to the growing intrusion of the pharmaceutical companies into medical education. These issues need to be discussed and clearly understood before the ACCME issues its final guidelines.

Two years ago I argued that our profession had made a serious mistake in the way it has allowed pharmaceutical companies to participate . . . [Full Text of this Article]

Author Affiliation: Harvard Medical School, Boston, Mass.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati     What's this?

RELATED LETTERS

Industry Sponsorship of Continuing Medical Education
Kurt J. Boyce, Jacqueline Parochka, and Karen Overstreet
JAMA. 2003;290(9):1149.
EXTRACT | FULL TEXT  

Industry Sponsorship of Continuing Medical Education
Jack E. Angel
JAMA. 2003;290(9):1149-1150.
EXTRACT | FULL TEXT  

Industry Sponsorship of Continuing Medical Education
Joel E. Cleary
JAMA. 2003;290(9):1150.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Industry Support of Medical Education
Relman
JAMA 2008;300:1071-1073.
FULL TEXT  

A Historical Perspective of Pharmaceutical Promotion and Physician Education
Podolsky and Greene
JAMA 2008;300:831-833.
FULL TEXT  

Conflict of Interest in Clinical Practice
Tonelli
Chest 2007;132:664-670.
ABSTRACT | FULL TEXT  

Optimizing Outcomes in Psychopharmacology Continuing Medical Education (CME): Measuring Learning and Attitudes That May Predict Knowledge Translation into Clinical Practice
Stahl et al.
Focus 2006;4:487.
ABSTRACT | FULL TEXT  

Narrative Review: The Promotion of Gabapentin: An Analysis of Internal Industry Documents
Steinman et al.
ANN INTERN MED 2006;145:284-293.
ABSTRACT | FULL TEXT  

Financial Disclosures of Scientific Papers Presented at the 2003 RSNA Annual Meeting: Association with Reporting of Non-Food and Drug Administration-approved Uses of Industry Products
Brown et al.
Radiology 2006;239:849-855.
ABSTRACT | FULL TEXT  

Current Status of Medical Grand Rounds in Departments of Medicine at US Medical Schools
Mueller et al.
Mayo Clin Proc. 2006;81:313-321.
ABSTRACT | FULL TEXT  

Financial Conflicts of Interest in Physicians' Relationships with the Pharmaceutical Industry -- Self-Regulation in the Shadow of Federal Prosecution
Studdert et al.
NEJM 2004;351:1891-1900.
FULL TEXT  

CME and the pharmaceutical industry: two worlds, three views, four steps
Davis
CMAJ 2004;171:149-150.
FULL TEXT  

The future sponsorship of CME in Canada: Industry, government, physicians or a blend?
Marlow
CMAJ 2004;171:150-151.
FULL TEXT  

State-mandated continuing medical education and the use of proven therapies in patients with an acute myocardial infarction
Patel et al.
J Am Coll Cardiol 2004;44:192-198.
ABSTRACT | FULL TEXT  

What's wrong with CME?
CMAJ 2004;170:917-917.
FULL TEXT  

Qu'est-ce qui ne va pas avec l'EMC?
CMAJ 2004;170:919-919.
FULL TEXT  

Industry Sponsorship of Continuing Medical Education
Boyce et al.
JAMA 2003;290:1149-1149.
FULL TEXT  

Industry Sponsorship of Continuing Medical Education
Cleary
JAMA 2003;290:1150-1150.
FULL TEXT  

Industry Sponsorship of Continuing Medical Education
Angel
JAMA 2003;290:1149-1150.
FULL TEXT